Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hamoud A. Alsamhan"'
Autor:
Ahmed S. Ali, Ibrahim M. Ibrahim, Abdulhadi S. Burzangi, Ragia H. Ghoneim, Hanin S. Aljohani, Hamoud A. Alsamhan, Jehan Barakat
Publikováno v:
Arabian Journal of Chemistry, Vol 14, Iss 10, Pp 103385- (2021)
Background: COVID-19 is an ongoing viral pandemic produced by SARS-CoV-2. In light of in vitro efficacy, several medications were repurposed for its management. During clinical use, many of these medications produced inconsistent results or had varyi
Externí odkaz:
https://doaj.org/article/4da1e3af4d9042bc87d5bbdcb5b9742a
Autor:
Abdelbagi Elfadil, Mousa, Hamoud Abdullah, Alsamhan, Hafsa Elawd, Mohamed Ahmed, Mohamed Abd Rhman, Adris Abdallah, Osman Mohamed, Elhadi Abdalla, Taroob Abdalwahab, Abdalhameed, Hamed Alneel, Albagir Ahmed, Sania Abdalla, Shaddad, Abdlrahim Abdlahman, Abdlhim, Hashim Ezeldin, Ibrahim Salih, Mawia Ahmed, Mustafa
Publikováno v:
Journal of the Pakistan Medical Association. 72:649-653
Objective: To provide evidence about the susceptibility of anti-malarial drugs, and to identify the clinical features of the disease in children. Method: The prospective observational comparative study was conducted at the Dongola Specialist Hospital
Autor:
Ahmed S. Ali, Mohammad W. Alrabia, Hamoud A. Alsamhan, Abdelbagi Alfadil, Hani Y. Abdullah, Huda M. Alkreathy
Publikováno v:
Journal of Pharmaceutical Research International. :198-207
Aims: To explore the antifungal activity of 2,3-dimethylquinoxaline. Study Design: A preclinical study of a compound against 10 fungal species. Backgrounds: Severe fungal infections cause significant clinical problem and need more effort to search fo
Autor:
Ragia H. Ghoneim, Ahmed S. Ali, Hamoud A. Alsamhan, Jehan Barakat, Abdulhadi S. Burzangi, Hanin S. Aljohani, Ibrahim M. Ibrahim
Publikováno v:
Arabian Journal of Chemistry
Arabian Journal of Chemistry, Vol 14, Iss 10, Pp 103385-(2021)
Arabian Journal of Chemistry, Vol 14, Iss 10, Pp 103385-(2021)
Background COVID-19 is an ongoing viral pandemic produced by SARS-CoV-2. In light of in vitro efficacy, several medications were repurposed for its management. During clinical use, many of these medications produced inconsistent results or had varyin